S&P 500 components Deere and Allstate are in focus for this week's stock market. Sea Ltd., Ollie's Bargain and Travere Therapeutics are also stocks to watch.
The major indexes fell sharply Friday after the Fed's favorite inflation gauge and inflation expectations came in hotter than expected.
Investors should be looking for stocks with strong relative strength for their watchlists, but it's not a great time to be adding exposure.
However, these five stocks are all near buy points or early entries.
Investors can also keep tabs on the IBD Leaderboard watchlist, the IBD 50 list of top growth stocks and IBD SwingTrader along with the IBD Sector Leaders list.
S&P 500: Deere Stock
Deere stock sank 3.3% to 465.03 in last week's stock market action. On Friday, the S&P 500 stock fell 3.1%, below its 50-day moving average.
Deere stock has formed a flat base with a traditional 515.05 buy point, according to MarketSurge charts. The S&P 500 stock has been finding support at its 50-day line and a clear move above the 490.58 high from March 27 could be actionable, as the stock would break a downtrend from the top of its base, the 515.05 high from Feb. 19.
In February, Deere posted fiscal first-quarter results that topped expectations. However, the company said uncertainty in the market, "particularly in North America," is weighing on sales.
Deere has been "underproducing," bringing down dealer inventories to normal levels. That will remove one headwind to sales. Yet the company still provided an outlook for sales of production and precision agricultural equipment to fall 15% to 20%, with small ag and turf sales down 10%.
Meanwhile, construction and forestry equipment sales are expected down 10% to 15%.
That outlook doesn't include "the uncertain and rapidly evolving environment" involving Trump administration policies, primarily tariffs.
Overall, Deere is sticking by its prior 2025 outlook of $5 billion to $5.5 billion in net income and $4.5 billion to $5.5 billion in net operating cash flow.
Deere stock has a 21-day average true range of 2.74%. The ATR metric is available on IBD's MarketSurge charting tool. It gauges the characteristic breadth of a stock's behavior. Stocks that tend to make large jumps or dives in daily action, the kind that can trigger sell rules and shake investors out of a stock, have a high ATR. Stocks that tend to make more incremental moves have lower ATRs.
In the current market, IBD suggests stocks with ATRs of 3% or below.
The S&P 500 stock has a robust 95 Composite Rating. Deere also has an 89 Relative Strength Rating and a 97 EPS Rating.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
Sea Ltd. Stock
SE shares advanced 3.7% to 130.70 last week, despite booking a 2.15% decline on Friday. Sea Ltd. stock is bouncing off its 10-week moving average as it builds a new consolidation just above prior base. The stock is actionable above its March 27 high of 136, according to MarketSurge chart analysis.
While still well below 2021 highs, Sea Ltd has followed up its 162% gain last year with a 23% rally to start 2025.
In early March, the Southeast Asia e-commerce leader announced sales jumped 37% in the final three months of 2024 as it boosted profitability.
Sea Ltd. reported that it earned 39 cents per share on sales of $4.95 billion for the December-ended quarter. For the same period a year earlier, SE stock posted a loss of 19 cents per share on sales of $3.62 billion.
Sea Ltd. is the owner of the Shopee e-commerce network, which is the market leader in Southeast Asia and also does business in Taiwan and parts of Latin America. Sea Ltd. also operates digital-payments provider SeaMoney and Garena, a global online games developer.
Overall revenue growth accelerated for a fourth straight quarter, with e-commerce sales growing 41.3% year over year. Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) for the e-commerce business swung to $152 million, vs. a $225 million loss for the same period a year earlier.
Sea Ltd. expects that Shopee can grow gross merchandise value by about 20% in 2025 while "improving profitability," according to Sea Ltd.'s press release.
Shopee's gross merchandise value grew 28% to $100.5 billion for 2024.
SE stock has a 21-day average true range of 5.3%. The stock has a perfect 99 Composite Rating. SE stock also has a robust 97 Relative Strength Rating and an 80 EPS Rating.
Ollie's Bargain Stock
OLLI stock jumped nearly 6% to 113.24 last week. The stock edged up Friday despite the broader market sell-off. Ollie's has formed a double-bottom base with a potential buy point at 115.42. OLLI appears to be actionable above its March 19 high of 111.71, according to MarketSurge analysis.
On March 19, the discount retailer announced a $300 million stock buyback and a ramp-up of store openings that offset lighter-than-expected quarterly sales.
Since its first share buyback in 2019, the company has repurchased $414 million, or 5.5 million shares.
Ollie's reported net sales rose 2.8% to $667.1 million in the January-ended quarter. The increase was driven by new-store growth and a comparable-store sales increase of 2.8%. The year-ago period got a $34 million boost from having an extra week in the prior fiscal year.
The retailer opened 13 stores in the quarter, ending with 559 stores in 31 states, an increase of 9.2%, and Ollie's is accelerating its store openings.
"With so many retailers closing stores or going bankrupt in the past year, there are a considerable number of abandoned customers, merchandise, real estate, and talent in the marketplace," Chief Executive Eric van der Valk told analysts.
Ollie's plans to open 75 stores in the fiscal year ending next January, up from an earlier target of 50. For the current fiscal year, the company forecast sales growth of 1% to 2%, or $2.564 billion to $2.586 billion, and same-store sales growth of 1% to 2%. It expects adjusted earnings per share of $3.65 to $3.75.
The stock has a 21-day average true range of 4.56%. OLLI has an 88 Composite Rating. The shares also have an 85 Relative Strength Rating and a 57 EPS Rating.
Futures Await 'Liberation Day' As Trump Tariffs Slam Stocks
Travere Therapeutics Stock
TVTX sank 4.1% last week, falling 3.4% on Friday, to 19.68. The biotech stock is now about 28% below a 25.29 consolidation buy point. However, the stock seems actionable above March 25 high of 21.35, which would be clearly above its 50-day line.
Shares are currently modestly below their 50-day line.
In February, Travere Therapeutics reached an agreement on what data the Food and Drug Administration would require to approve its drug, Filspari, for a second kidney disease.
Travere is planning to ask the FDA to sign off on Filspari as a treatment for focal segmental glomerulosclerosis, or FSGS, in the first quarter.
FSGS causes scarring on specific parts of the kidneys. Filspari is already approved to treat patients with IgA nephropathy, another kidney condition.
The biotech play was Friday's IBD Stock Of The Day.
TVTX stock has a 21-day average true range of 5.12%. The biotech stock has a 79 Composite Rating. The shares also have a strong 98 Relative Strength Rating and a 47 EPS Rating.
S&P 500: Allstate Stock
Allstate dipped 9 cents to 206.38 last week, as the S&P 500 insurance stock fell 1.4% on Friday. Allstate is holding just below a 209.88 buy point from a cup base.
The stock edged above the 209.88 buy point of a cup-without-handle base on Monday but faded below it. Thursday, shares made a second move above the entry in above-average volume. The buy zone goes as high as 220.37.
Allstate on March 20 reported estimated catastrophe losses for February of $92 million, or $73 million after tax. That's down sharply from January's loss of $1.08 billion, or $849 million after tax, due mainly to the California wildfires.
Total catastrophe losses for February year-to-date totaled $1.17 billion, or $922 million after tax, the company said. Policies in force rose 0.2% from January but down 0.3% year over year.
On Feb. 26, Allstate set a $1.5 billion share-repurchase program. That represented roughly 8 million shares at the time, or about 3% of shares outstanding.
Allstate's IBD's Insurance industry group is up 4.9% so far this year and ranks ninth out of the 197 industry group's tracked by IBD.
SPDR S&P Insurance ETF has formed a cup-with-handle base with a 60.81 buy point.
Jump-Start Your Investing Skills With IBD Digital
The S&P 500 insurance giant has a 21-day average true range of 2.54%. Allstate has a strong 97 Composite Rating. The stock also has an 88 Relative Strength Rating and a 76 EPS Rating.
Please follow Kit Norton on X @KitNorton for more coverage.
YOU MAY ALSO LIKE:
Is Tesla Stock A Buy Or A Sell?
Get Full Access To IBD Stock Lists And Ratings
Learning How To Pick Great Stocks? Read Investor's Corner
AI Is Fueling A 'Nuclear Renaissance.' Bill Gates And Jeff Bezos Are In The Mix.
The Lithium Price Cycle Has Bottomed. What To Expect Next For These Stocks.
